23rd Oct 2018 16:11
LONDON (Alliance News) - Allergy Therapeutics PLC said Tuesday that BlackRock Inc lowered its stake in the company to below the 5% threshold.
Prior to the deal, BlackRock held a 5.1% interest in the company.
Allergy Therapeutics shares were trading up 2.3% Tuesday at 18.00 pence each.
Related Shares:
Allergy Thera.